Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome

Clinical trial NCT00968708 · COMPLETED

Trial details

NCT number: NCT00968708
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 Acute Coronary Syndrome

Start date: 2009-09-01
Primary completion: 2013-04-01
Enrollment: 5380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.